Enterovirus 71 infection impairs the reproductive capacity of female mice

Qin,Bo; Yan,Qiuyue; Chen,Xing; Xu,Xiuping; Wang,Yanan; Chen,Jinkun; Dong,Xuejun

doi:10.3892/etm.2017.4499

Enterovirus 71 infection impairs the reproductive capacity of female mice

Authors:
- Bo Qin
- Qiuyue Yan
- Xing Chen
- Xiuping Xu
- Yanan Wang
- Jinkun Chen
- Xuejun Dong
View Affiliations

Affiliations: Clinical Laboratory Center, Shaoxing People's Hospital, Shaoxing Hospital of Zhejiang University, Shaoxing, Zhejiang 312000, P.R. China, Shaoxing Centre for Disease Control and Prevention, Shaoxing, Zhejiang 312000, P.R. China
Published online on: May 23, 2017 https://doi.org/10.3892/etm.2017.4499
Pages: 403-409

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

Enterovirus 71 (EV71) is a major cause of hand, foot and mouth disease (HFMD); however, no clinically approved vaccine or antiviral treatment is currently available for EV71 infection. In the present study, a murine model of EV71 infection was constructed. The clinical isolates of EV71 were amplified in Vero cells and used to challenge adult mice via hydrodynamic injection (HI) and intraperitoneal injection (IP). Following two challenges, >50% of the mice succumbed to EV71 infection. Surviving female mice were identified to have impaired fertility and their litter sizes were significantly decreased compared with the control group. The antibody against EV71‑VP1 persisted in the sera of female mice at a high titer for >2 years after challenge. The maternal antibody in the offspring sera also persisted for ~1 year and disappeared after ~2 years. Results from the present study suggest that a high titer of active EV71 was able to impair the reproductivity of adult female mice, and that high levels of maternal antibody persisted in the offspring and protected postnatal mice from EV71‑induced mortality. The promising antigenicity, immunogenicity and reactogenicity of EV71 suggests that it a potential vaccine target that may be beneficial to the control of HFMD, through immunizing infants and women of reproductive age.

View Figures

View References

1	Ye X, Fan C, Ku Z, Zuo T, Kong L, Zhang C, Shi J, Liu Q, Chen T, Zhang Y, et al: Structural basis for recognition of human enterovirus 71 by a bivalent broadly neutralizing monoclonal antibody. PLoS Pathog. 12:e10054542016. View Article : Google Scholar : PubMed/NCBI
2	Gui J, Liu Z, Zhang T, Hua Q, Jiang Z, Chen B, Gu H, Lv H and Dong C: Epidemiological characteristics and spatial-temporal clusters of hand, foot and mouth disease in zhejiang province, China, 2008–2012. PLoS One. 10:e01391092015. View Article : Google Scholar : PubMed/NCBI
3	Ho M, Chen ER, Hsu KH, Twu SJ, Chen KT, Tsai SF, Wang JR and Shih SR: An epidemic of enterovirus 71 infection in Taiwan. Taiwan Enterovirus Epidemic Working Group. N Engl J Med. 341:929–935. 1999. View Article : Google Scholar : PubMed/NCBI
4	Xu W, Liu CF, Yan L, Li JJ, Wang LJ, Qi Y, Cheng RB and Xiong XY: Distribution of enteroviruses in hospitalized children with hand, foot and mouth disease and relationship between pathogens and nervous system complications. Virol J. 9:82012. View Article : Google Scholar : PubMed/NCBI
5	Qin B, Zhang J, Xie W, Liu X, He T, Chen J and Dong X: Development of a specific latex agglutination test to detect antibodies of enterovirus 71. Arch Med Res. 46:580–587. 2015. View Article : Google Scholar : PubMed/NCBI
6	Qing J, Wang Y, Sun Y, Huang J, Yan W, Wang J, Su D, Ni C, Li J, Rao Z, et al: Cyclophilin A associates with enterovirus-71 virus capsid and plays an essential role in viral infection as an uncoating regulator. PLoS Pathog. 10:e10044222014. View Article : Google Scholar : PubMed/NCBI
7	Liu CC, Chow YH, Chong P and Klein M: Prospect and challenges for the development of multivalent vaccines against hand, foot and mouth diseases. Vaccine. 32:6177–6182. 2014. View Article : Google Scholar : PubMed/NCBI
8	Liang ZL, Mao QY, Wang YP, Zhu FC, Li JX, Yao X, Gao F, Wu X, Xu M and Wang JZ: Progress on the research and development of inactivated EV71 whole-virus vaccines. Hum Vaccin Immunother. 9:1701–1705. 2013. View Article : Google Scholar : PubMed/NCBI
9	Ren J, Wang X, Zhu L, Hu Z, Gao Q, Yang P, Li X, Wang J, Shen X, Fry EE, et al: Structures of Coxsackievirus A16 capsids with native antigenicity: Implications for particle expansion, receptor binding and immunogenicity. J Virology. 89:10500–10511. 2015. View Article : Google Scholar : PubMed/NCBI
10	Chang J, Li J, Wei W, Liu X, Liu G, Yang J, Zhang W and Yu XF: Determinants of EV71 immunogenicity and protection against lethal challenge in a mouse model. Immunol Res. 62:306–315. 2015. View Article : Google Scholar : PubMed/NCBI
11	Ng Q, He F and Kwang J: Recent Progress towards Novel EV71 anti-therapeutics and vaccines. Viruses. 7:6441–6457. 2015. View Article : Google Scholar : PubMed/NCBI
12	Li X, Fan P, Jin J, Su W, An D, Xu L, Sun S, Zhang Y, Meng X, Gao F, et al: Establishment of cell lines with increased susceptibility to EV71/CA16 by stable overexpression of SCARB2. Virol J. 10:2502013. View Article : Google Scholar : PubMed/NCBI
13	Wang YF, Chou CT, Lei HY, Liu CC, Wang SM, Yan JJ, Su IJ, Wang JR, Yeh TM, Chen SH and Yu CK: A mouse-adapted enterovirus 71 strain causes neurological disease in mice after oral infection. J Virol. 78:7916–7924. 2004. View Article : Google Scholar : PubMed/NCBI
14	Shih SR, Li YS, Chiou CC, Suen PC, Lin TY, Chang LY, Huang YC, Tsao KC, Ning HC, Wu TZ and Chan EC: Expression of capsid [correction of caspid] protein VP1 for use as antigen for the diagnosis of enterovirus 71 infection. J Med Virol. 61:228–234. 2000. View Article : Google Scholar : PubMed/NCBI
15	Bo HT: tCJkZJhJZjHXnFLjQ: A study on genetic characteristics of Enterovirus 71 of hand-foot-mouth disease in Shaoxing city Zhejiang. Prev Med. 26:42014.
16	Li XD, Li XF, Ye HQ, Deng CL, Ye Q, Shan C, Shang BD, Xu LL, Li SH, Cao SB, et al: Recovery of a chemically synthesized Japanese encephalitis virus reveals two critical adaptive mutations in NS2B and NS4A. J Gen Virol. 95:806–815. 2014. View Article : Google Scholar : PubMed/NCBI
17	Chen J, Zhao Y, Zhang C, Chen H, Feng J, Chi X, Pan Y, Du J, Guo M, Cao H, et al: Persistent hepatitis C virus infections and hepatopathological manifestations in immune-competent humanized mice. Cell Res. 24:1050–1066. 2014. View Article : Google Scholar : PubMed/NCBI
18	Shang B, Deng C, Ye H, Xu W, Yuan Z, Shi PY and Zhang B: Development and characterization of a stable eGFP enterovirus 71 for antiviral screening. Antiviral Res. 97:198–205. 2013. View Article : Google Scholar : PubMed/NCBI
19	Qin B, Tu C, Zhang B, He T, Fu L and Xu W: A modified murine model based on hydrodynamic injection for the analysis of chronic human hepatitis B virus infection. Mol Med Rep. 8:1677–1682. 2013.PubMed/NCBI
20	Qin B, Budeus B, Cao L, Wu C, Wang Y, Zhang X, Rayner S, Hoffmann D, Lu M and Chen X: The amino acid substitutions rtP177G and rtF249A in the reverse transcriptase domain of hepatitis B virus polymerase reduce the susceptibility to tenofovir. Antiviral Res. 97:93–100. 2013. View Article : Google Scholar : PubMed/NCBI
21	Chen IC, Wang SM, Yu CK and Liu CC: Subneutralizing antibodies to enterovirus 71 induce antibody-dependent enhancement of infection in newborn mice. Med Microbiol Immunol. 202:259–265. 2013. View Article : Google Scholar : PubMed/NCBI
22	Li P, Yue YY, Song NN, Li ZH and Meng H: Study on BALB/c mice with EV71 infection by diverse inoculation routes. Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi. 27:14–17. 2013.(In Chinese). PubMed/NCBI
23	Han JF, Yu N, Pan YX, He SJ, Xu LJ, Cao RY, Li YX, Zhu SY, Zhang Y and Qin ED: Phenotypic and genomic characterization of human coxsackievirus A16 strains with distinct virulence in mice. Virus Res. 179:212–219. 2014. View Article : Google Scholar : PubMed/NCBI
24	Teng S, Wei Y, Zhao SY, Lin XY, Shao QM and Wang J: Intestinal detoxification time of hand-foot-and-mouth disease in children with EV71 infection and the related factors. World J Pediatr. 11:380–385. 2015. View Article : Google Scholar : PubMed/NCBI
25	Klein MH: EV71 vaccines: A first step towards multivalent hand, foot and mouth disease vaccines. Expert Rev Vaccines. 14:337–340. 2015. View Article : Google Scholar : PubMed/NCBI